Literature DB >> 20063988

Mean platelet volume on admission correlates with impaired response to thrombolysis in patients with ST-elevation myocardial infarction.

David Pereg1, Tatiana Berlin, Morris Mosseri.   

Abstract

Mean platelets volume (MPV) has been shown to correlate with impaired reperfusion and increased mortality in patients with ST-elevation myocardial infarction (STEMI) treated with primary precutaneous coronary intervention (PCI). We aimed to study whether the same association exists in STEMI patients treated with thrombolysis. Included in the study were STEMI patients receiving thrombolysis. Thrombolysis failure was defined as a need for rescue precutaneous coronary intervention (PCI), in-hospital mortality, unplanned PCI during hospitalization or complete occlusion of the culprit coronary artery in a follow-up angiography. MPV levels were compared between patients with failed or successful thrombolysis. Of the 122 patients, 30 had failed thrombolysis while the other 92 fulfilled the criteria for successful treatment. There were no significant differences in demographic or clinical baseline characteristics of the two groups. Mean MPV was significantly higher in patients with failed thrombolysis compared to patients with successful treatment (9.2 +/- 1.1fl and 8.7 +/- 1.0fl respectively, p = 0.019 in multivariate analysis). The prevalence of thrombolysis failure was significantly higher in patients with MPV > 8.6 fl compared to those with MPV </= 8.6 fl (31.8% and 16% respectively, p = 0.048 in multivariate analysis). It appears that higher MPV correlates with thrombolysis failure in patients presenting with STEMI. MPV may be used as an adjunctive readily available factor for assessing thrombolysis outcome upon admission.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20063988     DOI: 10.3109/09537100903487599

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  11 in total

1.  Predictive value of CHA2DS2-VASc and CHA2DS2-VASc-HS scores for failed reperfusion after thrombolytic therapy in patients with ST-segment elevation myocardial infarction.

Authors:  Salih Kilic; Umut Kocabas; Levent Hurkan Can; Oğuz Yavuzgil; Mustafa Çetin; Mehdi Zoghi
Journal:  Cardiol J       Date:  2018-03-07       Impact factor: 2.737

2.  Mean platelet volume and cardiovascular outcomes in acute myocardial infarction.

Authors:  Mangalachulli Pottammal Ranjith; Rajendran DivyaRaj; Dolly Mathew; Biju George; Mangalath Narayanan Krishnan
Journal:  Heart Asia       Date:  2016-02-04

3.  Mean platelet volume can estimate the current vasculitis activity of microscopic polyangiitis.

Authors:  Ho Jae Kim; Seung Min Jung; Jason Jungsik Song; Yong-Beom Park; Sang-Won Lee
Journal:  Rheumatol Int       Date:  2018-03-19       Impact factor: 2.631

Review 4.  The causal role of megakaryocyte–platelet hyperactivity in acute coronary syndromes.

Authors:  John F Martin; Steen D Kristensen; Anthony Mathur; Erik L Grove; Fizzah A Choudry
Journal:  Nat Rev Cardiol       Date:  2012-11       Impact factor: 32.419

5.  Mean platelet volume is decreased in HIV-infected women.

Authors:  S Qadri; S Holman; J Dehovitz; H Crystal; H Minkoff; J M Lazar
Journal:  HIV Med       Date:  2013-06-05       Impact factor: 3.180

6.  Relationship of admission mean platelet volume, platelet distribution width and white blood cells with ST resolution in patients with acute ST segment elevation myocardial infarction treated with streptokinase without history of previous cardiovascular surgery.

Authors:  H R Varasteh-Ravan; Sadeq Ali-Hasan-Al-Saegh; Shohre Shokraneh; Mohammad R Mozayan; Ali Akbar Karimi-Bondarabadi
Journal:  Perspect Clin Res       Date:  2013-04

Review 7.  Mean platelet volume: a potential biomarker of the risk and prognosis of heart disease.

Authors:  Dong-Hyun Choi; Seong-Ho Kang; Heesang Song
Journal:  Korean J Intern Med       Date:  2016-10-24       Impact factor: 2.884

8.  Mean platelet volume and coronary plaque vulnerability: an optical coherence tomography study in patients with non-ST-elevation acute coronary syndrome.

Authors:  Jun Wang; Xing Li; Jun Pu; Siyu Jin; Lu Jia; Xiaomei Li; Fen Liu; Yining Yang
Journal:  BMC Cardiovasc Disord       Date:  2019-05-29       Impact factor: 2.298

9.  Polymorphisms of rs2483205 and rs562556 in the PCSK9 gene are associated with coronary artery disease and cardiovascular risk factors.

Authors:  Min-Tao Gai; Dilare Adi; Xiao-Cui Chen; Fen Liu; Xiang Xie; Yi-Ning Yang; Xiao-Ming Gao; Xiang Ma; Zhen-Yan Fu; Yi-Tong Ma; Bang-Dang Chen
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

10.  Nicotinic acid/laropiprant reduces platelet count but increases mean platelet volume in patients with primary dyslipidemia.

Authors:  Anastazia Kei; Moses Elisaf
Journal:  Arch Med Sci       Date:  2014-06-27       Impact factor: 3.318

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.